CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 24th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between James Edgemond (the “Employee”) and United Therapeutics Corporation, a Delaware corporation (the “Company”), effective as of November 12, 2014 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 24th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Maryland
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of March 13, 2015 (the “Effective Date”) by and between United Therapeutics Corporation (the “Company”) and James Edgemond (the “Executive”).
Third Amendment to Distribution Agreement (TYVASO®)Distribution Agreement • February 24th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations
THIS THIRD AMENDMENT TO DISTRIBUTION AGREEMENT (this “Third Amendment”) is made and effective this 20th Day of October, 2014 (the “Third Amendment Effective Date”) by and among, United Therapeutics Corporation, a Delaware corporation having offices at 1040 Spring Street, Silver Spring, Maryland (“UT”), Accredo Health Group, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822 (“Accredo”), CuraScript, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822 (“SP”) and Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation with offices at 255 Technology Park, Lake Mary, Florida, 32746 (“SD”). SP, SD and Accredo are collectively referred to herein as the “Distributor”.
